It feels like my oncologist
is always nearby
"I'm less worried when using this program"
SAFE@HOME
Safe@Home
Luscii provides the tools for patient and professional to keep an eye on the recovery while checking vital signs and symptoms to signal deteriorations and intervene timely in case of need.
What is the aim of the program?
- Prevents unnecessary outpatient clinic visits
- Prevents unnecessary ultrasounds
- Prevents unnecessary admissions and diagnostics
- Improves patient experience because the sense of security and less hospital visits
How does it work?
Pregnancy is often a wonderful experience for women, but it can also be worrisome if faced with risks such as hypertensive diseases like gestational hypertension, preeclampsia, and HELLP syndrome. Women at higher risk of these conditions are typically required to visit the outpatient clinic in the hospital for regular blood pressure monitoring. This can be particularly stressful for working women or those who already have children. However, by regularly reporting their blood pressure and completing questionnaires from the comfort of their homes, unnecessary hospital visits can be avoided. This approach offers a convenient and efficient way to manage hypertension during pregnancy, enabling women to receive the care they need while minimizing disruptions to their daily lives.
Developed by
Mireille Bekker
Professor Obstetrics
Publications
- Van Den Heuvel, J. F. M., Kariman, S. S., Van Solinge, W. W., Franx, A., Lely, A. T. & Bekker, M. N. (2019). SAFE@HOME – Feasibility study of a telemonitoring platform combining blood pressure and preeclampsia symptoms in pregnancy care. EJOG, 240, 226-231.
- Van Den Heuvel, J. F., Lely, A. T., Huisman, J., Trappenburg, J. C., Franx, A., & Bekker, M. N. (2020). SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study. Pregnancy Hypertension, 22, 30–36.
- Van Den Heuvel, J. F., Van Lieshout, C., Franx, A., Frederix, G. W., & Bekker, M. N. (2021). SAFE@HOME: Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia. Pregnancy Hypertension, 24, 118–123.
Price
€4.900,- (one-off)